Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients.

Literature DB >> 23260756

Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients.

Karin Hartmann, Nicola Wagner, Anja Rabenhorst, Liselotte Pflanz, Silke Leja, Anja Förster, Manuela Gehring, Alexander Kapp, Ulrike Raap.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 23260756 DOI： 10.1016/j.jaci.2012.11.008

Source DB: PubMed Journal: J Allergy Clin Immunol ISSN： 0091-6749 Impact factor: 10.793

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression.

Authors: A Mayado; C Teodosio; A C Garcia-Montero; A Matito; A Rodriguez-Caballero; J M Morgado; C Muñiz; M Jara-Acevedo; I Álvarez-Twose; L Sanchez-Muñoz; S Matarraz; C Caldas; J I Muñoz-González; L Escribano; A Orfao
Journal: Leukemia Date: 2015-07-08 Impact factor: 11.528

2. CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.

Authors: Georg Greiner; Nadine Witzeneder; Angelika Berger; Klaus Schmetterer; Gregor Eisenwort; Ana-Iris Schiefer; Simone Roos; Theresia Popow-Kraupp; Leonhard Müllauer; Johannes Zuber; Veronika Sexl; Lukas Kenner; Wolfgang R Sperr; Peter Valent; Matthias Mayerhofer; Gregor Hoermann
Journal: Blood Date: 2016-11-16 Impact factor: 22.113

3. Itch in dermatomyositis: the role of increased skin interleukin-31.

Authors: H J Kim; M Zeidi; D Bonciani; S M Pena; J Tiao; S Sahu; V P Werth
Journal: Br J Dermatol Date: 2018-06-21 Impact factor: 9.302

4. Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Authors: Anastasia I Petra; Irene Tsilioni; Alexandra Taracanova; Alexandra Katsarou-Katsari; Theoharis C Theoharides
Journal: Allergy Asthma Proc Date: 2018-03-01 Impact factor: 2.587

Review 5. Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis.

Authors: Isabelle Pastor Bandeira; André Eduardo de Almeida Franzoi; Giulia Murillo Wollmann; Washigton Luiz Gomes de Medeiros Junior; Wesley Nogueira Brandão; Jean Pierre Schatzmann Peron; Jefferson Becker; Osvaldo José Moreira Nascimento; Marcus Vinícius Magno Gonçalves
Journal: Neurol Sci Date: 2022-07-18 Impact factor: 3.830

Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients.

1. Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression.

2. CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.

3. Itch in dermatomyositis: the role of increased skin interleukin-31.

4. Interleukin 33 and interleukin 4 regulate interleukin 31 gene expression and secretion from human laboratory of allergic diseases 2 mast cells stimulated by substance P and/or immunoglobulin E.

Review 5. Interleukin-31 and soluble CD40L: new candidate serum biomarkers that predict therapeutic response in multiple sclerosis.

Review 6. IL-31: State of the Art for an Inflammation-Oriented Interleukin.

Review 7. The Return of the Mast Cell: New Roles in Neuroimmune Itch Biology.

Review 8. Interleukin-31: a novel diagnostic marker of allergic diseases.

Review 9. IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets.

Review 10. IL-31, itch and hematological malignancies.